In ASCVD, 81 mg and 325 mg of aspirin did not differ for CV or bleeding events.
Where this comes from
- Record sourced from PubMed, PMID 34606309.
- Also identified by DOI 10.7326/ACPJ202110190-118.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Jones WS, Mulder H, Wruck LM, et al. <b>Comparative effectiveness of aspirin dosing in cardiovascular disease.</b> N Engl J Med. 2021;384:1981-90. 33999548.
Medical subject headings
- Aspirin
- Cardiovascular Diseases